Jundishapur Journal of Natural Pharmaceutical Products

Published by: Kowsar

Effects of Fumaria parviflora L on Uremic Pruritus in Hemodialysis Patients: A Randomized, Double-Blind, Placebo-Controlled Trial

Rahimeh Akrami 1 , 2 , Mohammad Hashem Hashempur 3 , Ali Tavakoli 1 , Majid Nimrouzi 1 , 2 , Mehrab Sayadi 4 , Maryam Roodaki 4 , Jamshid Roozbeh 5 , * and Pouya Faridi 6 , *
Authors Information
1 Department of Traditional Medicine, School of Medicine, Shiraz University of Medical Sciences, Shiraz, IR Iran
2 Essence of Parsiyan Wisdom Institute, Traditional Medicine and Medicinal Plant Incubator, Shiraz University of Medical Sciences, Shiraz, IR Iran
3 Department of Traditional Medicine, School of Medicine, Fasa University of Medical Sciences, Fasa, IR Iran
4 Student Research Committee, Shiraz University of Medical Sciences, Shiraz, IR Iran
5 Department of Internal Medicine, Shiraz Nephro-Urology Research Center, Shiraz University of Medical Sciences, Shiraz, IR Iran
6 Department of Phytopharmaceuticals, School of Pharmacy and Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, IR Iran
Corresponding Authors:
Article information
  • Jundishapur Journal of Natural Pharmaceutical Products: August 2017, 12 (3 (Supp)); e39744
  • Published Online: September 17, 2016
  • Article Type: Research Article
  • Received: June 5, 2016
  • Revised: August 18, 2016
  • Accepted: August 29, 2016
  • DOI: 10.5812/jjnpp.39744

To Cite: Akrami R, Hashempur M H, Tavakoli A, Nimrouzi M, Sayadi M, et al. Effects of Fumaria parviflora L on Uremic Pruritus in Hemodialysis Patients: A Randomized, Double-Blind, Placebo-Controlled Trial, Jundishapur J Nat Pharm Prod. 2017 ; 12(3 (Supp)):e39744. doi: 10.5812/jjnpp.39744.

Abstract
Copyright © 2016, School of Pharmacy, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Acknowledgements
References
  • 1. Ko MJ, Peng YS, Chen HY, Hsu SP, Pai MF, Yang JY, et al. Interleukin-31 is associated with uremic pruritus in patients receiving hemodialysis. J Am Acad Dermatol. 2014; 71(6): 1151-1159 e1[DOI][PubMed]
  • 2. Aramwit P, Keongamaroon O, Siritientong T, Bang N, Supasyndh O. Sericin cream reduces pruritus in hemodialysis patients: a randomized, double-blind, placebo-controlled experimental study. BMC Nephrol. 2012; 13: 119[DOI][PubMed]
  • 3. Subach RA, Marx MA. Evaluation of uremic pruritus at an outpatient hemodialysis unit. Ren Fail. 2002; 24(5): 609-14[PubMed]
  • 4. Narita I, Alchi B, Omori K, Sato F, Ajiro J, Saga D, et al. Etiology and prognostic significance of severe uremic pruritus in chronic hemodialysis patients. Kidney Int. 2006; 69(9): 1626-32[DOI][PubMed]
  • 5. Wikstrom B. Itchy skin--a clinical problem for haemodialysis patients. Nephrol Dial Transplant. 2007; 22 Suppl 5: 3-7[DOI][PubMed]
  • 6. Akhyani M, Ganji MR, Samadi N, Khamesan B, Daneshpazhooh M. Pruritus in hemodialysis patients. BMC Dermatol. 2005; 5: 7[DOI][PubMed]
  • 7. Balaskas E, Szepietowski JC, Bessis D, Ioannides D, Ponticelli C, Ghienne C, et al. Randomized, double-blind study with glycerol and paraffin in uremic xerosis. Clin J Am Soc Nephrol. 2011; 6(4): 748-52[DOI][PubMed]
  • 8. Blachley JD, Blankenship DM, Menter A, Parker T3, Knochel JP. Uremic pruritus: skin divalent ion content and response to ultraviolet phototherapy. Am J Kidney Dis. 1985; 5(5): 237-41[PubMed]
  • 9. Wikstrom B, Gellert R, Ladefoged SD, Danda Y, Akai M, Ide K, et al. Kappa-opioid system in uremic pruritus: multicenter, randomized, double-blind, placebo-controlled clinical studies. J Am Soc Nephrol. 2005; 16(12): 3742-7[DOI][PubMed]
  • 10. Mettang T, Alscher DM, Pauli-Magnus C. Uremic Pruritus: New Perspectives and Insights from Recent Trials. Basic Clin Dermatol. 2004; 27: 193-204
  • 11. Mettang T, Pauli-Magnus C, Alscher DM. Uraemic pruritus--new perspectives and insights from recent trials. Nephrol Dial Transplant. 2002; 17(9): 1558-63[PubMed]
  • 12. Abbas AK, Murphy KM, Sher A. Functional diversity of helper T lymphocytes. Nature. 1996; 383(6603): 787-93[DOI][PubMed]
  • 13. de Jong R, Bezemer AC, Zomerdijk TP, van de Pouw-Kraan T, Ottenhoff TH, Nibbering PH. Selective stimulation of T helper 2 cytokine responses by the anti-psoriasis agent monomethylfumarate. Eur J Immunol. 1996; 26(9): 2067-74[DOI][PubMed]
  • 14. Fallahzadeh MK, Roozbeh J, Geramizadeh B, Namazi MR. Interleukin-2 serum levels are elevated in patients with uremic pruritus: a novel finding with practical implications. Nephrol Dial Transplant. 2011; 26(10): 3338-44[DOI][PubMed]
  • 15. Pakfetrat M, Basiri F, Malekmakan L, Roozbeh J. Effects of turmeric on uremic pruritus in end stage renal disease patients: a double-blind randomized clinical trial. J Nephrol. 2014; 27(2): 203-7[DOI][PubMed]
  • 16. Al-Qanunfil-teb 2005;
  • 17. Heydari M, Dalfardi B, Hashempur MH, Kolouri S. Johannitius (809-873AD), a bridge between Greek and Persian knowledge of the pulse. Int J Cardiol. 2016; 206: 112-3[DOI][PubMed]
  • 18. Hashempur MH, Lari ZN, Ghoreishi PS, Daneshfard B, Ghasemi MS, Homayouni K, et al. A pilot randomized double-blind placebo-controlled trial on topical chamomile (Matricaria chamomilla L.) oil for severe carpal tunnel syndrome. Complement Ther Clin Pract. 2015; 21(4): 223-8[DOI][PubMed]
  • 19. Alavi S. Makhzan Al-adviyah (The Storehouse of Medicaments). 2009;
  • 20. Fathiazad F, Hamedeyazdan S, Khosropanah MK, Khaki A. Hypoglycemic Activity of Fumaria parviflora in Streptozotocin-Induced Diabetic Rats. Adv Pharm Bull. 2013; 3(1): 207-10[DOI][PubMed]
  • 21. Najeeb ur R, Mehmood MH, Al-Rehaily AJ, Mothana RA, Gilani AH. Species and tissue-specificity of prokinetic, laxative and spasmodic effects of Fumaria parviflora. BMC Complement Altern Med. 2012; 12: 16[DOI][PubMed]
  • 22. Najeeb ur R, Bashir S, Al-Rehaily AJ, Gilani AH. Mechanisms underlying the antidiarrheal, antispasmodic and bronchodilator activities of Fumaria parviflora and involvement of tissue and species specificity. J Ethnopharmacol. 2012; 144(1): 128-37[DOI][PubMed]
  • 23. Gilani AH, Janbaz KH, Akhtar MS. Selective protective effect of an extract from Fumaria parviflora on paracetamol-induced hepatotoxicity. Gen Pharmacol. 1996; 27(6): 979-83[PubMed]
  • 24. Jowkar F, Jamshidzadeh A, Mirzadeh Yazdi A, Pasalar M. The effects of fumaria parviflora L extract on chronic hand eczema: a randomized double-blind placebo controlled clinical trial. Iran Red Crescent Med J. 2011; 13(11): 824-8[PubMed]
  • 25. Popova ME, Simanek V, Dolejs L, Smysl B, Preininger V. Alkaloids from Fumaria parviflora and F. kralikii. Planta Med. 1982; 45(2): 120-2[DOI][PubMed]
  • 26. Sousek J, Guedon D, Adam T, Bochorakova, H. , Taborska, E. , Valka, I. . Alkaloids and organic acids content of eight Fumaria species. Phytochem Analys. 1999; (1): 6-11
  • 27. Zamani-Moghaddam E, Azami K, Minaei-Zangi B, Mousavi SZ, Sabzevari O. Protective activity of Fumaria vaillantii extract and monomethyl fumarate on acetaminophen induced hepatotoxicity in mice. Int J Pharmacol. 2012; 8(3): 177-84[DOI]
  • 28. Pravenec M, Silhavy J, Zidek V, Mlejnek P, Landa V, Simakova M. Fumaric acid esters can block pro-inflammatory actions of human CRP and ameliorate metabolic disturbances in transgenic spontaneously hypertensive rats. Atherosclerosis. 2014; 235(2): 268[DOI]
  • 29. Litjens NH, Rademaker M, Ravensbergen B, Rea D, van der Plas MJ, Thio B, et al. Monomethylfumarate affects polarization of monocyte-derived dendritic cells resulting in down-regulated Th1 lymphocyte responses. Eur J Immunol. 2004; 34(2): 565-75[DOI][PubMed]
  • 30. Daugirdas JT. The post: pre-dialysis plasma urea nitrogen ratio to estimate K.t/V and NPCR: mathematical modeling. Int J Artif Organs. 1989; 12(7): 411-9[PubMed]
  • 31. Roozbeh J, Hashempur MH, Heydari M. Use of herbal remedies among patients undergoing hemodialysis. Iran J Kidney Dis. 2013; 7(6): 492-5[PubMed]
  • 32. Kimmel M, Alscher DM, Dunst R, Braun N, Machleidt C, Kiefer T, et al. The role of micro-inflammation in the pathogenesis of uraemic pruritus in haemodialysis patients. Nephrol Dial Transplant. 2006; 21(3): 749-55[DOI][PubMed]
  • 33. Virga G, Visentin I, La Milia V, Bonadonna A. Inflammation and pruritus in haemodialysis patients. Nephrol Dial Transplant. 2002; 17(12): 2164-9[PubMed]
  • 34. Chiu YL, Chen HY, Chuang YF, Hsu SP, Lai CF, Pai MF, et al. Association of uraemic pruritus with inflammation and hepatitis infection in haemodialysis patients. Nephrol Dial Transplant. 2008; 23(11): 3685-9[DOI][PubMed]
  • 35. Szepietowski JC, Morita A, Tsuji T. Ultraviolet B induces mast cell apoptosis: a hypothetical mechanism of ultraviolet B treatment for uraemic pruritus. Med Hypotheses. 2002; 58(2): 167-70[DOI][PubMed]
  • 36. Garssen J, Vandebriel RJ, De Gruijl FR, Wolvers DA, Van Dijk M, Fluitman A, et al. UVB exposure-induced systemic modulation of Th1- and Th2-mediated immune responses. Immunology. 1999; 97(3): 506-14[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments